» Articles » PMID: 27090602

Do People from Taiwan Have Higher Heavy Metal Levels Than Those from Western Countries?

Overview
Journal Singapore Med J
Specialty General Medicine
Date 2016 Apr 20
PMID 27090602
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: This study investigated whether heavy metal levels were higher in people from Taiwan as compared to those from Western countries.

Methods: We measured the level of heavy metals (lead, mercury, arsenic and cadmium) in the blood of 40 apparently healthy adults. Since mercury does not respond to ethylenediaminetetraacetic acid (EDTA) infusion, only urine lead, arsenic and cadmium levels were determined by applying the body burden concept after calcium disodium EDTA infusion. These three heavy metals were extracted from daily urine samples for three consecutive days.

Results: The mean blood lead, mercury and cadmium levels of the Taiwanese individuals (24.46 ± 9.69 µg/L, 9.64 ± 6.98 µg/L and 0.73 ± 0.27 µg/L, respectively) were greater than those of the Americans. The Taiwanese also had greater blood mercury and cadmium levels than the Germans. The first-day urine lead, arsenic and cadmium levels were 77.9%, 33.1% and 62.4%, respectively, of the total lead, arsenic and cadmium excretion during the three days. This indicates that the first-day urine lead and cadmium excretion represented most (> 60%) of the lead and cadmium excretion in those three days.

Conclusion: This study demonstrated that the Taiwanese population has higher blood mercury and cadmium levels than Western populations. To study the urine lead and cadmium body burden of patients, detection of first-day, rather than three-day, urine lead and cadmium levels can be done, as the former yields results that are fairly representative, and is more time- and cost-effective.

Citing Articles

Association of Urinary Lead and Cadmium Levels, and Serum Lipids with Subclinical Arteriosclerosis: Evidence from Taiwan.

Lin C, Hsu S, Chen C, Wang C, Sung F, Su T Nutrients. 2023; 15(3).

PMID: 36771277 PMC: 9919350. DOI: 10.3390/nu15030571.


Associations and Interactions between Heavy Metals with White Blood Cell and Eosinophil Count.

Huang C, Hsieh C, Wang C, Tu H, Chen S, Hung C Int J Med Sci. 2022; 19(2):331-337.

PMID: 35165518 PMC: 8795800. DOI: 10.7150/ijms.68945.


Association between Enzyme-Linked Immunosorbent Assay-Measured Kidney Injury Markers and Urinary Cadmium Levels in Chronic Kidney Disease.

Tsai K, Hsu P, Lee C, Kung C, Chang Y, Fu L J Clin Med. 2022; 11(1).

PMID: 35011897 PMC: 8745586. DOI: 10.3390/jcm11010156.


The Risk Factors of Blood Cadmium Elevation in Chronic Kidney Disease.

Tsai K, Hsu P, Kung C, Lee C, You H, Huang W Int J Environ Res Public Health. 2021; 18(23).

PMID: 34886064 PMC: 8656955. DOI: 10.3390/ijerph182312337.


Trend in blood lead levels in Taiwanese adults 2005-2017.

Fang C, Ning H, Huang Y, Chiang Y, Chuang C, Wang I PLoS One. 2021; 16(12):e0260744.

PMID: 34855854 PMC: 8638909. DOI: 10.1371/journal.pone.0260744.


References
1.
Khan D, Qayyum S, Saleem S, Khan F . Lead-induced oxidative stress adversely affects health of the occupational workers. Toxicol Ind Health. 2008; 24(9):611-8. DOI: 10.1177/0748233708098127. View

2.
Mitka M . Chelation therapy trials halted. JAMA. 2008; 300(19):2236. DOI: 10.1001/jama.2008.607. View

3.
Pollock C, Ibels L . Lead nephropathy--a preventable cause of renal failure. Int J Artif Organs. 1988; 11(2):75-8. View

4.
Lin J, Ho H, Yu C . Chelation therapy for patients with elevated body lead burden and progressive renal insufficiency. A randomized, controlled trial. Ann Intern Med. 1999; 130(1):7-13. DOI: 10.7326/0003-4819-130-1-199901050-00003. View

5.
Lin J, Lin-Tan D, Hsu K, Yu C . Environmental lead exposure and progression of chronic renal diseases in patients without diabetes. N Engl J Med. 2003; 348(4):277-86. DOI: 10.1056/NEJMoa021672. View